Market capitalization | $14.39b |
Enterprise Value | $19.03b |
P/E (TTM) P/E ratio | 46.54 |
EV/FCF (TTM) EV/FCF | 25.47 |
EV/Sales (TTM) EV/Sales | 2.79 |
P/S ratio (TTM) P/S ratio | 2.11 |
P/B ratio (TTM) P/B ratio | 2.59 |
Revenue growth (TTM) Revenue growth | -3.12% |
Revenue (TTM) Revenue | $6.82b |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
24 Analysts have issued a Avantor, Inc. forecast:
24 Analysts have issued a Avantor, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 6,820 6,820 |
3%
3%
|
|
Gross Profit | 2,212 2,212 |
8%
8%
|
|
EBITDA | 1,131 1,131 |
17%
17%
|
EBIT (Operating Income) EBIT | 726 726 |
24%
24%
|
Net Profit | 310 310 |
15%
15%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
Head office | United States |
CEO | Michael Stubblefield |
Employees | 14,500 |
Founded | 1904 |
Website | www.avantorsciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.